Skip to content

Effects of a Land and Aquatic Exercise-based Program on Pain, Mobility and Quality of Life in Patients With Chronic Low Back Pain

Effects of a Land and Aquatic Exercise-based Program on Pain, Mobility and Quality of Life in Patients With Chronic Low Back Pain: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06641570
Enrollment
41
Registered
2024-10-15
Start date
2024-09-30
Completion date
2025-04-30
Last updated
2025-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low-back Pain (cLBP)

Keywords

Pain, Exercise, Hydrotherapy, Aquatic Therapy, Disability

Brief summary

The goal of this randomized clinical trial\] is to study the effect of a combined aquatic and land-based exercise program compared to an aquatic program on pain, functional disability, and quality of life in adults with chronic low back pain. The main question it aims to answer is: Does a combined aquatic and land-based exercise program improve functional disability and quality of life and reduce pain in adults with chronic low back pain?. Participants will perform an aquatic exercise program (control group) or a combined aquatic and land-based exercise program (experimental group). Researchers will compare groups to find any differences in pain, funcional disability and quality of life.

Interventions

This intervention will include 16 sessions of an aquatic-exercise program, twice a week, over 8 weeks at a water temperature between 32-34°C. Each session will be conducted in groups of 8 to 12 patients and will last about 45 minutes.

This intervention will include 8 sessions in 8 weeks, once a week. Each session will last between 25 to 35 minutes and will be divided into two components: core stability exercises and stretching of the trunk and lower limbs.

Sponsors

Instituto Politécnico de Castelo Branco
CollaboratorUNKNOWN
Instituto Politécnico de Leiria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Both gender; * Portuguese nationality; * Aged over 18 years; * Chronic Low Back Pain lasting three months or longer and with an intensity of 3 or higher on the Visual Analogue Scale at rest.

Exclusion criteria

* Individuals who refuse to participate or do not provide informed consent; * Pain radiating to the lower limb; * Recent pregnancy or childbirth (less than 8 weeks ago); * Ongoing physical therapy treatments; * Severe rheumatological, neurological, neoplastic, cardiovascular diseases or other conditions that could prevent full participation in the intervention; * History of spinal surgery; * Inflammatory, infectious, or malignant spinal diseases; * Psychiatric disorders that may affect adherence and symptom assessment.

Design outcomes

Primary

MeasureTime frameDescription
PainFrom enrollment to the end of treatment at 8 weeksQuantitive variable evaluated with Visual Analogue Scale (Minimum: 0; Maximum 10). Higher values correspond to worse outcome.
Functional DisabilityFrom enrollment to the end of treatment at 8 weeksQuantitive variable evaluated with Oswestry Disability Index - version 2.0. (Minimum: 0; Maximum 100). Higher values correspond to worse outcome.
Quality of lifeFrom enrollment to the end of treatment at 8 weeksQuantitive variable evaluated with MOS Short Form Health Survey 36 Item v2. (Minimum: 0; Maximum 100). Higher values correspond to better outcome.

Secondary

MeasureTime frameDescription
Lumbar spine range of motionFrom enrollment to the end of treatment at 8 weeksQuantitive variable evaluated with Modified-Modified Schober Test.
Fear of movement or (re)injuryFrom enrollment to the end of treatment at 8 weeksQuantitive variable evaluated with Tampa Scale of Kinesiophobia-13. (Minimum: 13; Maximum 52). Higher values correspond to worse outcome.

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026